No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Prescription Drugs 17

No Prescription » Prescription Drugs 17

VENLOR Effexor XR

VENTOLIN INHALER Ventorlin

Ventorlin CFC Free Inhaler Proventil

VERADANAFIL Levitra

Vergo Generic Betahistine

Vermazol Vermox

Vermox Generic Mebendazole

Verpamil Calan

Verpamil SR Calan SR

VERTIN Serc

Viagra Revatio

Vicrom 5 Tilade

Vigamox Generic Moxifloxacin

Viraday Atripla

VIRAMUNE Generic Nevirapine

Virenza with Revolizer Relenza

Virosil Asiviral

Vitadol C Ascorbic acid

Vitamax Fish Oil

Vitamax Glucosamine Generic Glucosamine HCL

Vitamax Joint Mobility Generic Glucosamine Chondroitin

Vitamax Multivitamin Minerals Centrum

Vitamax Vitamin C

Vitamin A Protective Ointment

Vitamin B Complex

Vivatinell Acnecinamide Acne scrub

Volmax

Volmax Generic Salbutamol

Voltaren Cataflam

Voltaren Emulgel Generic Diclofenac

Voltaren Rapid Voveran

Voltaren SR Cataflam

Voritek Vfend

VOVERAN EMUGEL Voltaren

Voveran SR Voltaren SR

VOVERAN Voltaren

VYFAT orlistat

WARF Uniwarfin

X worm Albenza

Xalatan Generic Latanoprost

Xatral Uroxatral

XELODA Generic Capecitabine

orlistat Generic Orlistat

Xergic Telfast

XET Seroxat

Xylocaine Generic Lidocaine

Xylocaine Jelly Generic Lignocaine

XYLOCAINE Pump Spray Generic Lidocaine

Xyzal Generic Levocetririzine

Yasmin Generic Drospirenone Ethinyl Estradiol

ZAART H Hyzaar

Zantac Generic Ranitidine

Zarontin Generic Ethosuximide

Zarontin Syrup Generic Ethosuximide

Zeffix Generic Imaivudine

Zestril Prinivil

ZIDOVIR 300 AZT

ZIDOVIR AZT

Ziprax Suprax

Zipsydon Geodon

Zithromax Generic Azithromycin

Zitrotek Zithromax

ZOBID D Voltaren

Zocon Diflucan

Zocor

Zocor Forte Lipex

ZOFLUT Generic Fluticasone

Zofran Generic Ondansetron

Zoladex Generic Goserelin

Zoloft Lustral

Zomig Generic Zolmitriptan

ZONISEP Zonegran

Zoton Prevacid

Zovirax Generic Aciclovir

Zovirax Ophtalmic Pomade Generic Aciclovir

Zovirax Pump Pack Cream for Herpes Generic Aciclovir

Zurig Uloric

Zyban Wellbutrin

Zycolchin Colchicum

ZYLORIC Lopurin

Zymar Eye Drops Generic Gatifloxacin

Zynicor Ikorel

ZYRTEC Generic Cetirizine

Previous  Next

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.